| A novel system to categorize the symptoms of systemic lupus erythematosus DS Pisetsky, MEB Clowse, LG Criscione‐Schreiber, JL Rogers Arthritis Care & Research 71 (6), 735-741, 2019 | 69 | 2019 |
| Racial disparities in medication adherence between African American and Caucasian patients with systemic lupus erythematosus and their associated factors K Sun, AM Eudy, LG Criscione‐Schreiber, RE Sadun, JL Rogers, J Doss, ... ACR open rheumatology 2 (7), 430-437, 2020 | 34 | 2020 |
| Method and apparatus for testing for leaks in pipes J Conklin, J Rogers US Patent 3,750,711, 1973 | 30 | 1973 |
| Using clinical characteristics and patient‐reported outcome measures to categorize systemic lupus erythematosus subtypes JL Rogers, AM Eudy, D Pisetsky, LG Criscione-Schreiber, K Sun, J Doss, ... Arthritis care & research 73 (3), 386-393, 2021 | 24 | 2021 |
| Apoptotic debris accumulates on hematopoietic cells and promotes disease in murine and human systemic lupus erythematosus SA Kang, JL Rogers, AJ Monteith, C Jiang, J Schmitz, SH Clarke, ... The Journal of Immunology 196 (10), 4030-4039, 2016 | 23 | 2016 |
| Faculty development for underrepresented minority dental faculty and residents P Gates, N Ubu, L Smithey, J Rogers, NK Haden, T Rodriguez, ... Journal of dental education 77 (3), 276-291, 2013 | 18 | 2013 |
| Investigating health literacy in systemic lupus erythematosus: a descriptive review M Maheswaranathan, S Cantrell, AM Eudy, JL Rogers, MEB Clowse, ... Current allergy and asthma reports 20, 1-9, 2020 | 16 | 2020 |
| Cellular targeting in autoimmunity JL Rogers, DS Serafin, RG Timoshchenko, TK Tarrant Current allergy and asthma reports 12, 495-510, 2012 | 16 | 2012 |
| Physician counseling to prevent overweight in children and adolescents: American College of Preventive Medicine position statement RL Rodin, MH Alexander, VJ Guillory, J Rogers Journal of Public Health Management and Practice 13 (6), 655-661, 2007 | 16 | 2007 |
| Barriers to taking medications for systemic lupus erythematosus: a qualitative study of racial minority patients, lupus providers, and clinic staff K Sun, AL Corneli, C Dombeck, T Swezey, JL Rogers, ... Arthritis care & research 74 (9), 1459-1467, 2022 | 15 | 2022 |
| Hydroxychloroquine and COVID-19: a rheumatologist’s take on the lessons learned A Udupa, D Leverenz, SJ Balevic, RE Sadun, TK Tarrant, JL Rogers Current allergy and asthma reports 21, 1-10, 2021 | 15 | 2021 |
| Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms AM Eudy, JL Rogers, A Corneli, K McKenna, M Maheswaranathan, ... Lupus Science & Medicine 9 (1), e000705, 2022 | 13 | 2022 |
| Racial differences in patient-provider communication, patient self-efficacy, and their associations with systemic lupus erythematosus–related damage: a cross-sectional survey K Sun, AM Eudy, LG Criscione-Schreiber, RE Sadun, JL Rogers, J Doss, ... The Journal of rheumatology 48 (7), 1022-1028, 2021 | 12 | 2021 |
| The categorization of pain in systemic lupus erythematosus DS Pisetsky, AM Eudy, MEB Clowse, JL Rogers Rheumatic Disease Clinics 47 (2), 215-228, 2021 | 11 | 2021 |
| Loneliness predicts dementia-caregiver burden better than extent, nature and length of caregiving or support service-use M Pertl, J Rogers, A Galvin, M Maher, S Brennan, I Robertson, B Lawlor European Health Psychologist, 529-529, 2015 | 11 | 2015 |
| Low health numeracy is associated with higher disease activity in systemic lupus erythematosus M Maheswaranathan, AM Eudy, SC Bailey, JL Rogers, MEB Clowse Lupus 30 (3), 489-494, 2021 | 7 | 2021 |
| Successful treatment of painful cutaneous vasculopathy with rivaroxaban in a patient with systemic lupus erythematosus NH Leisenring, JL Rogers, S Telloni, P Mansoori, RN Al-Rohil, AL Marano J Drugs Dermatol 19 (5), 544-546, 2020 | 7 | 2020 |
| 102 A novel approach to addressing fibromyalgia symptomatology in SLE JL Rogers, AM Eudy, LG Criscione-Schreiber, DS Pisetsky, K Sun, J Doss, ... 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019 …, 2019 | 7 | 2019 |
| The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity AM Eudy, BB Reeve, T Coles, L Lin, JL Rogers, DS Pisetsky, ... Lupus 31 (6), 697-705, 2022 | 6 | 2022 |
| Catalytic reduction of acetobromo-sugars L Zervas, C Zioudrou, BOG Schuler, FL Warren, DA Craw, JL Rogers, ... J. Chem. Soc 214, 1956 | 6 | 1956 |
